DK3143018T3 - Carboxamidderivater - Google Patents

Carboxamidderivater Download PDF

Info

Publication number: DK3143018T3
Authority: DK; Denmark
Prior art keywords: carboxamide derivatives; carboxamide; derivatives
Prior art date: 2014-05-14

Application number

DK15725195.0T

Other languages

English (en)

Inventor

Anne-Marie D'souza

Mahbub Ahmed

Robert Alexander Pulz

Lisa Ann Rooney

Nichola Smith

Thomas Josef Troxler

Kamlesh Jagdis Bala

Andrew Brearley

James Dale

David Porter

David Andrew Sandham

Duncan Shaw

Jessica Louise Taylor

Roger John Taylor

Joe Wrigglesworth

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-05-14

Filing date

2015-05-14

Publication date

2021-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50735903&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3143018(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-05-14 Application filed by Novartis Ag filed Critical Novartis Ag

2021-05-31 Application granted granted Critical

2021-05-31 Publication of DK3143018T3 publication Critical patent/DK3143018T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DK15725195.0T 2014-05-14 2015-05-14 Carboxamidderivater DK3143018T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP14168303		2014-05-14
PCT/US2015/030817 WO2015175796A1 (en)	2014-05-14	2015-05-14	Carboxamide derivatives

Publications (1)

Publication Number	Publication Date
DK3143018T3 true DK3143018T3 (da)	2021-05-31

Family

ID=50735903

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15725195.0T DK3143018T3 (da)	2014-05-14	2015-05-14	Carboxamidderivater

Country Status (38)

Country	Link
US (6)	US9403810B2 (da)
EP (1)	EP3143018B1 (da)
JP (1)	JP6523338B2 (da)
KR (2)	KR20230074827A (da)
CN (1)	CN106661012B (da)
AP (1)	AP2016009550A0 (da)
AR (1)	AR100440A1 (da)
AU (1)	AU2015259083B2 (da)
BR (1)	BR112016026552B1 (da)
CA (1)	CA2948543C (da)
CL (1)	CL2016002839A1 (da)
CR (1)	CR20160527A (da)
CU (1)	CU24434B1 (da)
CY (1)	CY1124251T1 (da)
DK (1)	DK3143018T3 (da)
EA (1)	EA030938B1 (da)
ES (1)	ES2874882T3 (da)
HR (1)	HRP20210783T1 (da)
HU (1)	HUE054590T2 (da)
IL (1)	IL248785B (da)
JO (1)	JO3610B1 (da)
LT (1)	LT3143018T (da)
MA (1)	MA39983B1 (da)
MX (1)	MX2016014939A (da)
MY (1)	MY186598A (da)
PE (1)	PE20171443A1 (da)
PH (1)	PH12016502246A1 (da)
PL (1)	PL3143018T3 (da)
PT (1)	PT3143018T (da)
RS (1)	RS61874B1 (da)
SG (1)	SG11201609217UA (da)
SI (1)	SI3143018T1 (da)
SV (1)	SV2016005313A (da)
TN (1)	TN2016000489A1 (da)
TW (2)	TW201946921A (da)
UY (1)	UY36124A (da)
WO (1)	WO2015175796A1 (da)
ZA (1)	ZA201607658B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201946921A (zh)	2014-05-14	2019-12-16	瑞士商諾華公司	甲醯胺衍生物
US9403833B2 (en)	2014-05-14	2016-08-02	Novartis Ag	Carboxamide derivatives
CA3081424A1 (en) *	2017-11-01	2019-05-09	Bristol-Myers Squibb Company	Spirocyclic compounds as farnesoid x receptor modulators
CN108689976B (zh) *	2018-07-23	2021-12-28	陕西师范大学	5-磺基水杨酸协同二氯二茂钛催化合成4-碘代四氢吡喃衍生物的方法
EP4211171A2 (en)	2020-09-10	2023-07-19	Precirix N.V.	Antibody fragment against fap
WO2023203135A1 (en)	2022-04-22	2023-10-26	Precirix N.V.	Improved radiolabelled antibody
WO2023213801A1 (en)	2022-05-02	2023-11-09	Precirix N.V.	Pre-targeting

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2655009A1 (de)	1976-12-04	1978-06-15	Hoechst Ag	Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US7354722B1 (en)	1999-06-11	2008-04-08	Signal Pharmaceuticals	Modulators of Smurf and BMP/TGFβ signaling pathways
JP2003502064A (ja) *	1999-06-11	2003-01-21	ザリサーチファウンデーションオブステイトユニバーシティーオブニューヨーク	ＢＭＰおよびＴＧＦβシグナル伝達経路のアンタゴニスト
CA2514733A1 (en)	2003-02-28	2004-09-16	Transform Pharmaceuticals, Inc.	Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
GB0312368D0 (en)	2003-05-30	2003-07-02	Univ Aston	Novel ureido- and amido-pyrazolone derivatives
US20060281803A1 (en)	2003-09-23	2006-12-14	Lindsley Craig W	Pyrazole modulators of metabotropic glutamate receptors
US7291743B2 (en)	2005-03-29	2007-11-06	Geneblue Corporation	Isoxazole derivatives and methods of treating nitric oxide mediated diseases
WO2008121861A2 (en)	2007-03-28	2008-10-09	Xenon Pharmaceuticals Inc.	Pyrazole and pyrrole compounds useful in treating iron disorders
US20090069288A1 (en)	2007-07-16	2009-03-12	Breinlinger Eric C	Novel therapeutic compounds
CN101796036A (zh)	2007-08-02	2010-08-04	欧加农股份有限公司	作为trpv1调节剂的5-苯基异噁唑-3-甲酰胺衍生物
ES2477878T3 (es)	2007-08-22	2014-07-18	Irm Llc	Compuestos y composiciones de 5-(4-(aloalcoxi)fenil)pirimidin-2-amina como inhibidores de quinasas
WO2009086303A2 (en) *	2007-12-21	2009-07-09	University Of Rochester	Method for altering the lifespan of eukaryotic organisms
WO2011151361A1 (en)	2010-06-03	2011-12-08	Glaxo Group Limited	Novel compounds
CA2823877C (en)	2011-02-18	2020-01-07	Actelion Pharmaceuticals Ltd	Novel pyrazole and imidazole derivatives useful as orexin antagonists
US20170088546A1 (en) *	2014-05-14	2017-03-30	Novartis Ag	Carboxamide inhibitors
US9403833B2 (en) *	2014-05-14	2016-08-02	Novartis Ag	Carboxamide derivatives
MX2016014878A (es)	2014-05-14	2017-03-08	Pfizer	Pirazolopiridinas y pirazolopirimidinas.
TW201946921A (zh)	2014-05-14	2019-12-16	瑞士商諾華公司	甲醯胺衍生物

2015
- 2015-05-13 TW TW108119419A patent/TW201946921A/zh unknown
- 2015-05-13 TW TW104115287A patent/TWI714528B/zh active
- 2015-05-13 US US14/711,684 patent/US9403810B2/en active Active
- 2015-05-14 CR CR20160527A patent/CR20160527A/es unknown
- 2015-05-14 PE PE2017000546A patent/PE20171443A1/es unknown
- 2015-05-14 CA CA2948543A patent/CA2948543C/en active Active
- 2015-05-14 JP JP2016567570A patent/JP6523338B2/ja active Active
- 2015-05-14 WO PCT/US2015/030817 patent/WO2015175796A1/en active Application Filing
- 2015-05-14 CN CN201580038353.3A patent/CN106661012B/zh active Active
- 2015-05-14 AU AU2015259083A patent/AU2015259083B2/en active Active
- 2015-05-14 MY MYPI2016704043A patent/MY186598A/en unknown
- 2015-05-14 HU HUE15725195A patent/HUE054590T2/hu unknown
- 2015-05-14 UY UY0001036124A patent/UY36124A/es active IP Right Grant
- 2015-05-14 AP AP2016009550A patent/AP2016009550A0/en unknown
- 2015-05-14 TN TN2016000489A patent/TN2016000489A1/en unknown
- 2015-05-14 SI SI201531605T patent/SI3143018T1/sl unknown
- 2015-05-14 PT PT157251950T patent/PT3143018T/pt unknown
- 2015-05-14 MA MA39983A patent/MA39983B1/fr unknown
- 2015-05-14 CU CU2016000166A patent/CU24434B1/es unknown
- 2015-05-14 DK DK15725195.0T patent/DK3143018T3/da active
- 2015-05-14 EP EP15725195.0A patent/EP3143018B1/en active Active
- 2015-05-14 AR ARP150101498A patent/AR100440A1/es active IP Right Grant
- 2015-05-14 KR KR1020237016401A patent/KR20230074827A/ko not_active Application Discontinuation
- 2015-05-14 EA EA201692300A patent/EA030938B1/ru not_active IP Right Cessation
- 2015-05-14 SG SG11201609217UA patent/SG11201609217UA/en unknown
- 2015-05-14 ES ES15725195T patent/ES2874882T3/es active Active
- 2015-05-14 PL PL15725195T patent/PL3143018T3/pl unknown
- 2015-05-14 BR BR112016026552-1A patent/BR112016026552B1/pt active IP Right Grant
- 2015-05-14 KR KR1020167034559A patent/KR102534033B1/ko active IP Right Grant
- 2015-05-14 MX MX2016014939A patent/MX2016014939A/es active IP Right Grant
- 2015-05-14 LT LTEP15725195.0T patent/LT3143018T/lt unknown
- 2015-05-14 JO JOP/2015/0119A patent/JO3610B1/ar active
- 2015-05-14 RS RS20210629A patent/RS61874B1/sr unknown
2016
- 2016-06-16 US US15/184,730 patent/US10195181B2/en active Active
- 2016-11-06 IL IL248785A patent/IL248785B/en active IP Right Grant
- 2016-11-07 ZA ZA2016/07658A patent/ZA201607658B/en unknown
- 2016-11-09 CL CL2016002839A patent/CL2016002839A1/es unknown
- 2016-11-11 PH PH12016502246A patent/PH12016502246A1/en unknown
- 2016-11-11 SV SV2016005313A patent/SV2016005313A/es unknown
2018
- 2018-12-21 US US16/230,033 patent/US20190381011A1/en not_active Abandoned
2020
- 2020-05-14 US US16/874,595 patent/US20200268718A1/en not_active Abandoned
- 2020-11-04 US US17/089,064 patent/US11672782B2/en active Active
2021
- 2021-05-14 HR HRP20210783TT patent/HRP20210783T1/hr unknown
- 2021-06-04 CY CY20211100488T patent/CY1124251T1/el unknown
2023
- 2023-05-16 US US18/317,990 patent/US20230301970A1/en active Pending

Also Published As

Publication number	Publication date
EA030938B1 (ru)	2018-10-31
US20230301970A1 (en)	2023-09-28
JO3610B1 (ar)	2020-08-27
HUE054590T2 (hu)	2021-09-28
PH12016502246B1 (en)	2017-01-09
CA2948543A1 (en)	2015-11-19
MA39983B1 (fr)	2021-05-31
MX2016014939A (es)	2017-02-28
CL2016002839A1 (es)	2017-01-27
IL248785B (en)	2020-04-30
EP3143018B1 (en)	2021-03-10
US20200268718A1 (en)	2020-08-27
MY186598A (en)	2021-07-29
HRP20210783T1 (hr)	2021-06-25
CU24434B1 (es)	2019-09-04
CN106661012B (zh)	2019-12-20
CN106661012A (zh)	2017-05-10
US9403810B2 (en)	2016-08-02
CU20160166A7 (es)	2017-03-03
US10195181B2 (en)	2019-02-05
ES2874882T3 (es)	2021-11-05
AU2015259083B2 (en)	2017-09-14
MA39983A (fr)	2017-03-22
PE20171443A1 (es)	2017-09-29
CR20160527A (es)	2017-04-28
BR112016026552A2 (pt)	2017-08-15
KR20230074827A (ko)	2023-05-31
JP2017515853A (ja)	2017-06-15
TW201946921A (zh)	2019-12-16
AP2016009550A0 (en)	2016-11-30
EP3143018A1 (en)	2017-03-22
KR102534033B1 (ko)	2023-05-19
US20170014388A1 (en)	2017-01-19
US11672782B2 (en)	2023-06-13
US20210052554A1 (en)	2021-02-25
IL248785A0 (en)	2017-01-31
NZ725918A (en)	2023-09-29
CY1124251T1 (el)	2022-07-22
BR112016026552B1 (pt)	2023-02-14
LT3143018T (lt)	2021-06-10
SV2016005313A (es)	2018-06-12
JP6523338B2 (ja)	2019-05-29
BR112016026552A8 (pt)	2021-07-06
UY36124A (es)	2016-01-08
AU2015259083A1 (en)	2016-11-24
RS61874B1 (sr)	2021-06-30
EA201692300A1 (ru)	2017-04-28
SI3143018T1 (sl)	2021-08-31
PH12016502246A1 (en)	2017-01-09
PT3143018T (pt)	2021-06-01
US20150329529A1 (en)	2015-11-19
ZA201607658B (en)	2017-09-27
WO2015175796A1 (en)	2015-11-19
CA2948543C (en)	2022-08-16
KR20170003666A (ko)	2017-01-09
SG11201609217UA (en)	2016-12-29
TW201623296A (zh)	2016-07-01
TN2016000489A1 (en)	2018-04-04
PL3143018T3 (pl)	2021-08-30
TWI714528B (zh)	2021-01-01
AR100440A1 (es)	2016-10-05
US20190381011A1 (en)	2019-12-19

Publication	Publication Date	Title
DK3319956T3 (da)	2021-03-29	Substituerede oxopyridinderivater
DK3204359T3 (da)	2020-09-14	Tetrahydroisoquinolinderivater
DK3110442T3 (da)	2020-12-14	Modificerede meningokok-fhbp-polypeptider
DK3231803T3 (da)	2020-08-24	Dihydroindolizinonderivat
DE112015001664A5 (de)	2016-12-29	Betätigungsaktuator
DK3131898T3 (da)	2020-05-11	Fluoroalkylfluorenderivativer
DK3143018T3 (da)	2021-05-31	Carboxamidderivater
AP2016009554A0 (en)	2016-11-30	Carboxamide derivatives
FR3023290B1 (fr)	2016-08-19	Derives de flavaglines
DE112015005041A5 (de)	2017-08-31	Gargerätevorrichtung
DE102014000623A8 (de)	2016-10-13	Halbhohlnietelement
DE112015001633A5 (de)	2017-02-23	Betätigungsaktuator
DE202014005655U8 (de)	2014-11-13	llluminationsvorrichtung
IL248801A0 (en)	2017-01-31	Carboxamide history
DK3119744T3 (da)	2019-05-20	2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamidderivater
DE112015005055A5 (de)	2017-08-03	Gargerätevorrichtung
BR112016030599A2 (pt)	2017-08-15	novos derivados de aminoalquilbenzotiazepina e suas utilizações
TH1501004330A (th)	2017-10-12	อนุพันธ์อะโซลเบนซีน
TH1601000368A (th)	2018-04-05	อนุพันธ์ควินอลีน
TH1501006974A (th)	2017-09-21	อนุพันธ์เฮเทอโรไซคลิค
UA28615S (uk)	2014-12-25	Сірник
DE102014112481A8 (de)	2016-04-14	Axialfederanordnung
UA28476S (uk)	2014-12-10	Сірник
BR302014001855S1 (pt)	2015-06-16	Configuração aplicada em bolsa
BR302014001854S1 (pt)	2015-06-16	Configuração aplicada em bolsa